Literature DB >> 20134429

Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis.

Quinn P Peterson1, David R Goode, Diana C West, Rachel C Botham, Paul J Hergenrother.   

Abstract

This protocol describes the gram-scale solution-phase synthesis of the colorimetric caspase-3/7 substrate Ac-DEVD-pNA. The caspase enzymes are integral to cellular inflammation and apoptotic cascades, and are commonly studied by cell biologists, medicinal chemists and chemical biologists. In particular, the assessment of caspase enzymatic activity is a standard method to evaluate cell death pathways and new apoptosis-modulating agents. Caspase enzymatic activity can be conveniently monitored with peptidic chromogenic or fluorogenic substrates, with certain peptide sequences imparting selectivity for certain caspases. The synthesis of these peptide substrates is typically carried out by solid-phase synthesis, a method that is not ideal for production of the gram quantities needed for high-throughput screening. Described herein is a facile method for the synthesis of the Ac-DEVD-pNA caspase-3/7 substrate using solution-phase peptide synthesis. This protocol, involving iterative PyBOP-mediated couplings and Fmoc deprotections, is rapid (about 5 d), operationally simple and can be used to generate over 1 g of product at a fraction of the cost of the commercial substrate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134429      PMCID: PMC2921128          DOI: 10.1038/nprot.2009.223

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  51 in total

1.  Irreversible caspase inhibitors: tools for studying apoptosis.

Authors:  J C Wu; L C Fritz
Journal:  Methods       Date:  1999-04       Impact factor: 3.608

2.  A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.

Authors:  N A Thornberry; T A Rano; E P Peterson; D M Rasper; T Timkey; M Garcia-Calvo; V M Houtzager; P A Nordstrom; S Roy; J P Vaillancourt; K T Chapman; D W Nicholson
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

3.  Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.

Authors:  L J Martin
Journal:  J Neuropathol Exp Neurol       Date:  1999-05       Impact factor: 3.685

4.  Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas.

Authors:  Young Hwa Soung; Jong Woo Lee; Su Young Kim; Yong Jik Sung; Won Sang Park; Suk Woo Nam; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Oncogene       Date:  2005-01-06       Impact factor: 9.867

5.  CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas.

Authors:  Young Hwa Soung; Jong Woo Lee; Su Young Kim; Jin Jang; Yong Gyu Park; Won Sang Park; Suk Woo Nam; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

6.  Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma.

Authors:  Evzen Krepela; Jan Procházka; Xiaoyi Liul; Pavel Fiala; Zdenĕk Kinkor
Journal:  Biol Chem       Date:  2004-02       Impact factor: 3.915

7.  Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia.

Authors:  Z Estrov; P F Thall; M Talpaz; E H Estey; H M Kantarjian; M Andreeff; D Harris; Q Van; M Walterscheid; S M Kornblau
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

Review 8.  Huntington's disease: molecular basis of neurodegeneration.

Authors:  David C Rubinsztein; Jenny Carmichael
Journal:  Expert Rev Mol Med       Date:  2003-08-22       Impact factor: 5.600

9.  A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

Authors:  S Mandruzzato; F Brasseur; G Andry; T Boon; P van der Bruggen
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

10.  Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation.

Authors:  Yang Chao; Eric N Shiozaki; Srinivasa M Srinivasula; Daniel J Rigotti; Robert Fairman; Yigong Shi
Journal:  PLoS Biol       Date:  2005-05-10       Impact factor: 8.029

View more
  12 in total

1.  Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

Authors:  Danny C Hsu; Howard S Roth; Diana C West; Rachel C Botham; Chris J Novotny; Steven C Schmid; Paul J Hergenrother
Journal:  ACS Comb Sci       Date:  2011-10-28       Impact factor: 3.784

2.  Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound.

Authors:  Quinn P Peterson; Danny C Hsu; Chris J Novotny; Diana C West; Dewey Kim; Joanna M Schmit; Levent Dirikolu; Paul J Hergenrother; Timothy M Fan
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

3.  Cytotoxicity, cytocompatibility, cell-labeling efficiency, and in vitro cellular magnetic resonance imaging of gadolinium-catalyzed single-walled carbon nanotubes.

Authors:  Pramod K Avti; Elisabeth D Caparelli; Balaji Sitharaman
Journal:  J Biomed Mater Res A       Date:  2013-05-18       Impact factor: 4.396

4.  Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

Authors:  Howard S Roth; Paul J Hergenrother
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  S51 Family Peptidases Provide Resistance to Peptidyl-Nucleotide Antibiotic McC.

Authors:  Eldar Yagmurov; Konstantin Gilep; Marina Serebryakova; Yuri I Wolf; Svetlana Dubiley; Konstantin Severinov
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

6.  Noninvasive bioluminescence imaging of the dynamics of sanguinarine induced apoptosis via activation of reactive oxygen species.

Authors:  Yan Wang; Beilei Zhang; Wei Liu; Yunpeng Dai; Yaru Shi; Qi Zeng; Fu Wang
Journal:  Oncotarget       Date:  2016-04-19

7.  CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.

Authors:  Laboni Mondal; Biswajit Mukherjee; Kaushik Das; Sanchari Bhattacharya; Debasmita Dutta; Shreyasi Chakraborty; Murari Mohan Pal; Raghuvir H Gaonkar; Mita Chatterjee Debnath
Journal:  Int J Nanomedicine       Date:  2019-10-09

8.  Addition of L-arginine in skim milk extender maintains goat spermatozoa quality in chilled temperature for five days.

Authors:  Suherni Susilowati; Indah Norma Triana; Wurlina Wurlina; Arimbi Arimbi; Pudji Srianto; Imam Mustofa
Journal:  Vet World       Date:  2019-11-15

9.  Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.

Authors:  Gang Niu; Lei Zhu; Don N Ho; Fan Zhang; Haokao Gao; Qimeng Quan; Naoki Hida; Takeaki Ozawa; Gang Liu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-02-21       Impact factor: 11.556

10.  A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis.

Authors:  Ji-Hee Kim; Dong-Keon Lee; Joohwan Kim; Seunghwan Choi; Wonjin Park; Kwon-Soo Ha; Tae-Hoon Kim; Jongseon Choe; Moo-Ho Won; Young-Guen Kwon; Young-Myeong Kim
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.